Liposomes, Part F (eBook)
416 Seiten
Elsevier Science (Verlag)
978-0-08-096102-6 (ISBN)
Liposomes are cellular structures made up of lipid molecules, which are water insoluable organic molecules and the basis of biological membranes. Important as a cellular model in the study of basic biology, liposomes are also used in clinical applications such as drug delivery and virus studies. Liposomes Part ,F is a continuation of previous MIE Liposome volumes A through E.
* One of the most highly respected publications in the field of biochemistry since 1955 * Frequently consulted, and praised by researchers and reviewers alike * Truly an essential publication for anyone in any field of the life sciences
Liposomes are cellular structures made up of lipid molecules, which are water insoluble organic molecules and the basis of biological membranes. Important as a cellular model in the study of basic biology, liposomes are also used in clinical applications such as drug delivery and virus studies. Liposomes Part F is a continuation of previous MIE Liposome volumes A through E. - One of the most highly respected publications in the field of biochemistry since 1955- Frequently consulted and praised by researchers and reviewers alike- Truly an essential publication for anyone in any field of the life sciences
Front Cover
1
Methods in Enzymology
4
Copyright
5
Contents
6
Contributors
12
Preface
18
Section 1: Bioactive Liposomes
48
Chapter 1: Tubular Liposomes with Variable Permeability for Reconstitution of FtsZ Rings
50
1. Introduction
51
2. Reagents
51
3. Bacterial Expression of Membrane Targeting FtsZ
52
4. Purification of FtsZ-mts and FtsZ-YFP-mts
52
5. Renatured Preparation of FtsZ-YFP-mts
54
6. Tubular Multilamellar Liposome Preparation
54
7. Permeability of the Multilamellar Liposomes
56
8. Z-ring Formation in Liposomes
58
9. A Crude Flow Chamber to Exchange Buffer Outside Liposomes
58
10. Factors Affecting Z-ring Formation in Liposomes
61
11. Utility of the Liposomes Beyond FtsZ
63
References 63
Chapter 2: Detection and Analysis of Protein Synthesis and RNA Replication in Giant Liposomes
66
1. Introduction
67
2. Methods
68
3. Analysis of the FACS Data
74
4. Conclusions
75
Acknowledgments 76
References 76
Chapter 3: Construction of Cell-Sized Liposomes Encapsulating Actin and Actin-Cross-linking Proteins
78
1. Introduction
79
2. Experimental Section
84
3. Morphogenesis of Giant Liposomes Encapsulating Actin and Its Cross-linking Proteins
89
4. Concluding Remarks
96
Acknowledgments 97
References 97
Chapter 4: Reconstitution of Membrane Budding with Unilamellar Vesicles 102
1. Introduction
103
2. M Protein Purification
104
3. Evaluation of the Membrane Activity of M Protein Through its Interaction with Intermediate-Sized Unilamellar Liposomes
105
4. Reconstitution of M-Protein-Driven Membrane Budding on GUVs
113
5. Concluding Remarks
120
References 120
Section 2: Liposomes and Nanotechnology
124
Chapter 5: Detection of Antimycolic Acid Antibodies by Liposomal Biosensors 126
1. Introduction
127
2. Experimental
128
3. Conclusion
149
Acknowledgments 149
References 149
Chapter 6: Solid Lipid Nanoparticle Formulations: Pharmacokinetic and Biopharmaceutical Aspects in Drug Delivery 152
1. Introduction
153
2. Production of SLN
154
3. Pharmacokinetics and Pharmacodynamics
154
4. Modified Release Profile
159
5. Biopharmaceutical Aspects of Administration Routes
161
6. Clinical Pharmacology
164
7. Concluding Remarks
168
References 169
Chapter 7: Preparation of Complexes of Liposomes with Gold Nanoparticles 178
1. Introduction
179
2. Preparation of Complexes of EYPC Liposomes with Au NPs
181
3. Time-Dependent SPR of the Complexes
181
4. TEM Analysis of the Complexes
183
5. DLS Analysis of the Complexes
184
6. Calcein Release from the Complexes
184
7. Estimation of Numbers of the Au NP and the Liposome in the Complexes
186
8. Optimization of Lipid Components of the Complexes
187
9. Concluding Remarks
189
Acknowledgment
190
References 191
Chapter 8: Bio-Nanocapsule-Liposome Conjugates for In Vivo Pinpoint Drug and Gene Delivery
194
1. Introduction
195
2. First-Generation Bio-Nanocapsules
196
3. Second-Generation BNCs
197
4. Retargeting of BNC-LP Conjugates
199
5. Overexpression of BNCs in S. cerevisiae
200
6. Conjugation of BNCs with LPs
202
7. Preparation of Antibody-Displaying BNC-LP Conjugates
208
8. Preparation of Biotin-Displaying BNC-LP Conjugates
210
9. Concluding Remarks
210
Acknowledgments 211
References 211
Chapter 9: Nanoliposomal Dry Powder Formulations 214
1. Introduction
215
2. Preparation of Nanoliposomal DPFs
216
3. Physicochemical Characterization of NLDPFs
221
4. Concluding Remarks
234
References 235
Chapter 10: Lanthanide-Loaded Paramagnetic Liposomes as Switchable Magnetically Oriented Nanovesicles 240
1. Introduction
241
2. Paramagnetic Ln(III)-Based Shift Reagents
242
3. Preparation of Osmotically Shrunken Liposomes
244
4. NMR Characterization of Magnetically Oriented Nonspherical Liposomes
245
5. Sample Experiments
247
6. Concluding Remarks
255
Acknowledgments 255
References 255
Chapter 11: Reconstitution of Membrane Proteins in Phospholipid Bilayer Nanodiscs 258
1. Introduction
259
2. Overview of Nanodisc Technology
259
3. Reconstitution Considerations
265
4. Optimizing the Reconstitution for P-glycoprotein
270
Acknowledgments 275
References 275
Chapter 12: DNA-Controlled Assembly of Liposomes in Diagnostics 280
1. Introduction
281
2. Probe Design
282
3. General Description of Materials and Techniques
291
4. Concluding Remarks
294
Acknowledgment
294
References 295
Chapter 13: Soft Hybrid Nanostructures Composed of Phospholipid Liposomes Decorated with Oligonucleotides
296
1. Introduction
297
2. Materials
298
3. Liposome Preparation and Determination of Lipid Content
299
4. Incorporation of Oligonucleotides
300
5. Characterization of the Soft Hybrid Nanostructure
303
6. Applications of Oligo-Decorated Liposomes
309
7. Challenges and Perspectives
322
Acknowledgments 323
References 323
Chapter 14: Synthesis, Characterization, and Optical Response of Gold Nanoshells Used to Trigger Release from Liposomes 326
1. Introduction
327
2. Synthesis of HGNs
330
3. Optimization of HGN Dimensions for Maximum Absorption in the NIR
333
4. HGN Response to Femtosecond NIR Laser Pulses
337
5. Coupling HGN to Liposomes
341
6. Liposome Disruption and CF Release Due to Pulsed Laser Irradiation
346
7. Mechanism of Triggered Liposome Release
347
8. Effect of Proximity of HGNs to Liposomes
350
9. Conclusions
351
Acknowledgments 351
References 351
Chapter 15: Complex Nanotube-Liposome Networks 356
1. Introduction
356
2. Network Fabrication Protocols
357
3. Complexity and Topology
361
4. Internal and Membrane Functionalization
362
5. Transport Phenomena and Controlled Mixing Procedures
365
6. Enzymatic Reactions in NVN
367
7. Concluding Remarks
370
Acknowledgments 370
References 371
Chapter 16: Bionanotubules Formed from Liposomes 374
1. Introduction
375
2. Bionanotubule Formation by Applying Electric Fields to Surface-Attached Liposomes
376
3. Bionanotubule Formation from Liposomes in Solution Using Electric Fields
381
4. Other Methods of Bionanotubule Formation from Liposomes
384
5. Concluding Remarks
386
References 386
Chapter 17: Engineering Cationic Liposome: siRNA Complexes for In Vitro and In Vivo Delivery
390
1. Introduction
391
2. Cationic Liposome Systems for siRNA Delivery
392
3. Experimental Methods
394
4. Troubleshooting
399
5. Concluding Remarks
400
References 401
Author Index
402
Subject Index
410
Color Plates
418
Tubular Liposomes with Variable Permeability for Reconstitution of FtsZ Rings
Masaki Osawa; Harold P. Erickson Department of Cell Biology, Duke University Medical Center, Durham, North Carolina, USA
Abstract
We have developed a system for producing tubular multilamellar liposomes that incorporate the protein FtsZ on the inside. We start with a mixture of spherical multilamellar liposomes with FtsZ initially on the outside. Shearing forces generated by applying a coverslip most likely distort some of the spherical liposomes into a tubular shape, and causes some to leak and incorporate FtsZ inside. We describe protocols for liposome preparation, and for preparing membrane-targeted FtsZ that can assemble contractile Z rings inside the tubular liposomes. We also describe the characterization of the multilamellar liposomes in terms of the permeability or leakiness for a small fluorescent dye and larger protein molecules. These liposomes may be useful for reconstitution of other biological systems.
1 INTRODUCTION
FtsZ is a bacterial tubulin homologue that forms a ring structure called the “Z ring” at the division plane in bacteria. The Z ring is anchored to the membrane and constricts to divide the bacteria. FtsZ recruits a dozen other essential division proteins, which are mostly involved in remodeling the peptidoglycan cell wall. We recently succeeded in reconstituting Z rings inside tubular liposomes, and found that they generated a constriction force on the liposome wall (Osawa et al., 2008). The assembly of Z rings and the generation of the constriction force were achieved with FtsZ alone, and did not require any other division protein. This was an important discovery itself for understanding the mechanism of bacterial cell division. Now the liposome system we developed should provide a simple in vitro system for studying molecular details of how FtsZ works.
To achieve these results we had to overcome two technical problems. The first problem was to tether FtsZ to the membrane. Pichoff and Lutkenhaus (2005) discovered that the carboxy terminus of FtsZ binds to FtsA, and FtsA has an amphipathic helix at its carboxy terminal that inserts into the membrane. We made an FtsZ that could tether itself to the membrane by fusing an amphipathic helix (membrane targeting sequence: mts) to the carboxy terminus of FtsZ. To visualize the protein, we inserted a yellow fluorescent protein (YFP) before the mts, giving FtsZ-YFP-mts. Here we provide detailed protocols for the purification of FtsZ-YFP-mts.
The second problem was how to get the protein inside liposomes. We have succeeded in getting FtsZ-YFP-mts inside spherical unilamellar liposomes using the emulsion method (Noireaux and Libchaber, 2004; Pautot et al., 2003). However, we have never found Z rings assembled in such spherical unilamellar liposomes.
Eventually, we discovered a procedure that produced tubular multilamellar liposomes, and incorporated FtsZ-YFP-mts inside, where it formed Z rings. Initially this was a fortunate accident, since the cylindrical geometry was not designed, and the FtsZ was initially on the outside. We have since refined the procedures for producing tubular multilamellar liposomes, and we now understand some aspects of the permeability or leakiness that lets FtsZ inside. We describe here our protocols for producing the tubular liposomes and the tests of permeability.
2 REAGENTS
The following reagents are used in our experiments:
• Column buffer: 50 mM Tris/HCl, pH 7.9, 50 mM KCl, 1 mM EDTA, 10% (v/v) glycerol
• HMKCG buffer: 50 mM HEPES/KOH, pH 7.7, 5 mM MgAc, 300 mM KAc, 50 mM KCl 10% (v/v) glycerol
• HMK50-350 buffer: 50 mM HEPES/KOH, pH 7.7, 5 mM MgAc, 50–350 mM KAc
• DOPG:1,2-dioleoyl-sn-glycero-3-[phospho-rac-(1-glycerol)] (Avanti)
• Egg PC: phosphatidylcholine (Avanti)
• HccA: 7-Hydroxycoumarin-3-carboxylic acid (Invitrogen)
• Teflon disc, 37 mm diameter
3 BACTERIAL EXPRESSION OF MEMBRANE TARGETING FTSZ
The FtsZ-YFP-mts is expressed from a pET-11b expression vector, with FtsZ366-YFP-mts or FtsZ366-mts genes inserted at NdeI/BamHI sites (366 indicates that the FtsZ was truncated there, removing the FtsA-binding C-terminal peptide). The YFP we use is the variety Venus (Nagai et al., 2002), which gave superior results in FtsZ fusions in E. coli (Osawa and Erickson, 2005). The mts used here is the amphipathic helix from E. coli MinD (Szeto et al., 2003). We have not yet tested the amphipathic helix from FtsA, which has three to five additional extra amino acids that extend the amphipathic helix (Pichoff and Lutkenhaus, 2005). The expression vector is transformed into E. coli strain C41 (Miroux and Walker, 1996), which gives better yields of soluble proteins than BL21.
After transforming, colonies are selected on an LB (Luria broth) agar plate containing 100 μg/ml ampicillin. A colony is picked and cultured overnight in 50 ml LB media with 100 μg/ml ampicillin at 37 °C.
Five milliliters of the overnight culture is diluted in 500 ml LB and cultured at 37 °C until the optical density at 600 nm reaches 0.8–1.0. Protein expression is induced by addition of 0.5 mM IPTG and at the same time the temperature of the shaker is set to 20 °C (our shaker takes 1–2 h to reach 20 °C).
The cells are cultured overnight and spun down at 3750 rpm for 45 min in a Beckman GPR rotor.
4 PURIFICATION OF FTSZ-MTS AND FTSZ-YFP-MTS
Since FtsZ-mts and FtsZ-YFP-mts are expressed as soluble proteins, we purify them using the same protocol as for wild-type FtsZ.
The packed cells are resuspended in a final volume of 20 ml column buffer, and 1 mM phenylmethanesulphonylfluoride (PMSF) and 0.1–0.2 mg/ml lysozyme are added. The mixture is then incubated on a rotator at 4 °C for 15 min. They are frozen at 80 °C overnight or longer.
Two cycles of freeze–thaw (fresh 1 mM PMSF is added after each thawing) method are performed. The resultant mixture is sonicated on ice until the viscosity is reduced. We usually sonicate it for three cycles of 20 s, with 1 min cooling intervals.
It is then centrifuged at 32,000 rpm for 20 min at 4 °C (Beckman 42.1 Ti rotor). The supernatant is collected and ammonium sulfate is added to 30% saturation (3.52 g dry ammonium sulfate to the 20 ml volume). This mixture is incubated for 20 min on ice and again centrifuged at 32,000 rpm for 20 min at 4 °C (Beckman 42.1 Ti rotor). The supernatant is discarded and the pellet is resuspended in 10 ml column buffer and passed through a 0.22 μm filter.
The protein is purified on an anion exchange column. A 1 × 10 cm Source Q column (Source 15Q, GE Healthcare) is used. The column is eluted with a 100 ml gradient from 50–500 mM KCl in column buffer.
4.1 For FtsZ-mts
FtsZ has very low UV absorbance, so the peak is located by running each fraction on SDS–PAGE.
The peak fractions are pooled and dialyzed into HMK350.
The protein concentration is determined by the BCA method (Pierce). FtsZ produces 75% as much color as BSA (Lu et al., 1998), so it is necessary to correct for this.
Aliquots are frozen and stored at − 80 °C.
4.2 For FtsZ-YFP-mts
After elution from the Source 15Q column, the peak fractions are pooled. There are typically two peaks: a large main peak and a following small peak, and both peaks have an indistinguishable activity. These peaks can be identified by yellow fluorescence and confirmed by SDS–PAGE.
They are concentrated using an Amicon Ultra-15 with centrifugation at 5000×g.
We have noted that incomplete boiling of FtsZ-YFP-MTS with SDS sample buffer generates two bands on the gel. The upper band (68 Kd) results from completely denatured protein and the lower band (60 Kd), which still has yellow fluorescence in the gel, is due to FtsZ-YFP-mts where the YFP is not denatured.
The concentration of FtsZ-YFP-mts can be determined from its absorption at 515 nm, using the extinction coefficient for YFP-Venus 92,200 M− 1 cm− 1.
Our preferred buffer for FtsZ-YFP-mts is now HMKCG because FtsZ-YFP-mts seems to be more stable, as described below; we now use HMKCG for dialysis, dilution, reaction, and storage buffer.
5 RENATURED PREPARATION OF FTSZ-YFP-MTS
In our previous study (Osawa et al., 2008), we used a renaturing technique to prepare FtsZ366-YFP-mts. We developed this protocol because an early preparation...
Erscheint lt. Verlag | 6.11.2009 |
---|---|
Sprache | englisch |
Themenwelt | Medizin / Pharmazie |
Naturwissenschaften ► Biologie ► Biochemie | |
Naturwissenschaften ► Biologie ► Genetik / Molekularbiologie | |
Naturwissenschaften ► Biologie ► Zellbiologie | |
Naturwissenschaften ► Physik / Astronomie ► Angewandte Physik | |
Technik | |
ISBN-10 | 0-08-096102-9 / 0080961029 |
ISBN-13 | 978-0-08-096102-6 / 9780080961026 |
Haben Sie eine Frage zum Produkt? |
Kopierschutz: Adobe-DRM
Adobe-DRM ist ein Kopierschutz, der das eBook vor Mißbrauch schützen soll. Dabei wird das eBook bereits beim Download auf Ihre persönliche Adobe-ID autorisiert. Lesen können Sie das eBook dann nur auf den Geräten, welche ebenfalls auf Ihre Adobe-ID registriert sind.
Details zum Adobe-DRM
Dateiformat: EPUB (Electronic Publication)
EPUB ist ein offener Standard für eBooks und eignet sich besonders zur Darstellung von Belletristik und Sachbüchern. Der Fließtext wird dynamisch an die Display- und Schriftgröße angepasst. Auch für mobile Lesegeräte ist EPUB daher gut geeignet.
Systemvoraussetzungen:
PC/Mac: Mit einem PC oder Mac können Sie dieses eBook lesen. Sie benötigen eine
eReader: Dieses eBook kann mit (fast) allen eBook-Readern gelesen werden. Mit dem amazon-Kindle ist es aber nicht kompatibel.
Smartphone/Tablet: Egal ob Apple oder Android, dieses eBook können Sie lesen. Sie benötigen eine
Geräteliste und zusätzliche Hinweise
Buying eBooks from abroad
For tax law reasons we can sell eBooks just within Germany and Switzerland. Regrettably we cannot fulfill eBook-orders from other countries.
aus dem Bereich